OBJECTIVE: Rare de novo variants in GNAO1 cause a severe neurodevelopmental disorder characterized by a heterogenous display of early onset epilepsy, movement abnormalities, and global developmental delay. More than 100 pathogenic variants in GNAO1 have been identified and categorized into four groups according to their protein features. Most pathogenic variants affect both GNAO1 isoforms, whereas approximately 20% of patients have a GNAO1A-specific variant. Response to therapy is notoriously...
Source: PubMed - functional seizures
ยทPublished 05 Nov 2026 ยทImported 05 Nov 2026
Relevancy: Not reviewed
Read the article